Categories
Business

Global Gene Therapy Market Aggregate to USD 3.2 Billion 2026 – Facts & Factors

Global Gene Therapy Market Growing On The Back Of The Rising Commercialization, Increasing Investment By Major Pharma In Research And Development, Expanding Approval Portfolio, Growing Market In US And Europe

Gene therapy is a major part of the pharmaceutical industry. The therapy concentrates on the treatment of the patients through the modification of genes. The treatment involves the replacement of the defective genes with a healthy set of genes for curing patients.

The worldwide demand for the Gene Therapy market was estimated at around USD 1.4 billion in 2019, and by the end of 2026, existing and expected developments would hit valuations of around USD 3.4 billion. The industry players and analysts predict the global Gene Therapy market growth of around14.7% in terms of CAGR.

Get a Free Sample of this report Here

The gene therapy market has witnessed increased involvement of the players attracted by the business model. The participants have active involvement in investments from the commercial as well as non-commercial investors. Research and development in the industry is been actively pursued by many entities that as anticipated to reach commercial status globally. The industry is actively witnessing notable investment in molecular and cellular biology coupled with faster advancement in the segment of genomics. Market development consists of increasing competition coupled with the enhanced premiums globally. The market participants are actively pursuing decreasing the overall prices for increased accessibility across the population.

During the upcoming years, the rising commercialization, increasing investment by major pharma in research and development, expanding approval portfolio, growing market in the US and Europe are expected to drive the market growth throughout the forecast period. The increasing number of participants and the rising prevalence of the diseases are further propelling the market growth. The inadequate reimbursement policies and threat possessed by the randomized controlled trials are expected to challenge the intended growth of the market.

Top Market Players

  • Advanced Cell & Gene Therapy,
  • Audentes Therapeutics,
  • Benitec Biopharma,
  • Biogen,
  • Blubird Bio Inc.,
  • Bristol-Myers Squibb Company,
  • CHIESI Farmaceutici SPA,
  • Eurofins Scientific,
  • Geneta Science,
  • Genzyme Corporation,
  • Gilead,
  • GlaxoSmithKline PLC

To know an additional revised 2020 list of market players, request a sample report

On the basis of type, the worldwide Gene Therapy market can be segmented into Germ Line Gene Therapy and Somatic Gene Therapy. Somatic gene therapy is anticipated to generate maximum revenue during the studied period. The involvement in a wide range of disorders treatment is anticipated to propel the market growth. In terms of vector type, the global Gene Therapy market can be segmented into Viral Vectors, Non-Viral Vectors, and Human Artificial Chromosome. Based on the therapy area, the market can be bifurcated into Cancer, Neurological Diseases, Infectious Diseases, Genetic Disorders, Rheumatoid Arthritis, and Others. In terms of geography, The North American market is expected to dominate the sales of the global market. Robust healthcare services, changes in payment strategies, and strong per capita healthcare expenditure are anticipated to drive the demand in the region.  The regional segmentation includes North America, Europe, Latin America, and Middle East & Africa in the global Gene Therapy market.

Frequently Asked Questions

What is Gene Therapy?

Gene therapy is a major part of the pharmaceutical industry. The therapy concentrates on the treatment of the patients through the modification of genes. The treatment involves the replacement of the defective genes with a healthy set of genes for curing patients.

What are the key factors driving Gene Therapy Market expansion?

The Rising Commercialization, Increasing Investment By Major Pharma In Research And Development, Expanding Approval Portfolio, Growing Market In US And Europe is projected to raise demand for the Gene Therapy market.

Request a customized copy of the report HERE

What will be the value of Gene Therapy Market during 2020- 2026?

The Global Gene Therapy market is expected to generate revenue of around USD 3.4 Billion by end of 2026, growing at a CAGR of around 14.7% between 2020 and 2026.

Which region will make notable contributions towards global Gene Therapy Market revenue?

The North American market is expected to dominate the sales of the global market. Robust healthcare services, changes in payment strategies, and strong per capita healthcare expenditure are anticipated to drive the demand in the region.

Which are the key players leveraging Gene Therapy Market growth?

Some of the leading and top Gene Therapy companies in the global Gene Therapy market include Advanced Cell & Gene Therapy, Audentes Therapeutics, Benitec Biopharma, Biogen, Blubird Bio, Inc., Bristol-Myers Squibb Company, CHIESI Farmaceutici SPA, Eurofins Scientific, Geneta Science, Genzyme Corporation, Gilead, GlaxoSmithKline PLC, Human Stem Cells institute, Novartis AG, Orchard Therapeutics, Pfizer Inc., Sangamo therapeutics, Spark therapeutics, and Voyager Therapeutics among others.